메뉴 건너뛰기




Volumn 16, Issue 5, 2014, Pages 363-372

Pharmacological Management of Narcolepsy and Cataplexy in Pediatric Patients

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

EID: 84922020508     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.1007/s40272-014-0083-3     Document Type: Review
Times cited : (22)

References (87)
  • 3
    • 0037086990 scopus 로고    scopus 로고
    • The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study
    • PID: 11902429
    • Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197–202.
    • (2002) Sleep , vol.25 , Issue.2 , pp. 197-202
    • Silber, M.H.1    Krahn, L.E.2    Olson, E.J.3    Pankratz, V.S.4
  • 5
    • 84874783317 scopus 로고    scopus 로고
    • ImmunoChip study implicates antigen presentation to T cells in narcolepsy
    • PID: 23459209, COI: 1:CAS:528:DC%2BC3sXkt1WltrY%3D
    • Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013;9(2):e1003270.
    • (2013) PLoS Genet , vol.9 , Issue.2 , pp. e1003270
    • Faraco, J.1    Lin, L.2    Kornum, B.R.3    Kenny, E.E.4    Trynka, G.5    Einen, M.6
  • 6
    • 0034846670 scopus 로고    scopus 로고
    • Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy
    • PID: 11558795, COI: 1:CAS:528:DC%2BD3MXntFalt7s%3D
    • Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, et al. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001;50(3):381–8.
    • (2001) Ann Neurol , vol.50 , Issue.3 , pp. 381-388
    • Nishino, S.1    Ripley, B.2    Overeem, S.3    Nevsimalova, S.4    Lammers, G.J.5    Vankova, J.6
  • 7
    • 84892655928 scopus 로고    scopus 로고
    • De la Herrán-Arita AK et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Transl Med. 2013;5:216ra176
    • De la Herrán-Arita AK et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci Transl Med. 2013;5:216ra176. doi:10.1126/scitranslmed.3007762
  • 8
    • 77954948437 scopus 로고    scopus 로고
    • Hypocretins in the control of sleep and wakefulness
    • PID: 20425032, COI: 1:CAS:528:DC%2BC3cXht1CjsL3E
    • Bonnavion P, de Lecea L. Hypocretins in the control of sleep and wakefulness. Curr Neurol Neurosci Rep. 2010;10(3):174–9.
    • (2010) Curr Neurol Neurosci Rep , vol.10 , Issue.3 , pp. 174-179
    • Bonnavion, P.1    de Lecea, L.2
  • 10
    • 0035846568 scopus 로고    scopus 로고
    • Age at onset of narcolepsy in two large populations of patients in France and Quebec
    • PID: 11739821, COI: 1:STN:280:DC%2BD3Mnpt1Kjuw%3D%3D
    • Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology. 2001;57(11):2029–33.
    • (2001) Neurology , vol.57 , Issue.11 , pp. 2029-2033
    • Dauvilliers, Y.1    Montplaisir, J.2    Molinari, N.3    Carlander, B.4    Ondze, B.5    Besset, A.6
  • 11
    • 0036467285 scopus 로고    scopus 로고
    • Clinical aspects of narcolepsy–cataplexy across ethnic groups
    • PID: 11833858
    • Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsy–cataplexy across ethnic groups. Sleep. 2002;25(1):27–35.
    • (2002) Sleep , vol.25 , Issue.1 , pp. 27-35
    • Okun, M.L.1    Lin, L.2    Pelin, Z.3    Hong, S.4    Mignot, E.5
  • 12
    • 84878361343 scopus 로고    scopus 로고
    • Genetic association, seasonal infections and autoimmune basis of narcolepsy
    • PID: 23497937, COI: 1:CAS:528:DC%2BC3sXktlGmu7c%3D
    • Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. 2013;43:26–31.
    • (2013) J Autoimmun , vol.43 , pp. 26-31
    • Singh, A.K.1    Mahlios, J.2    Mignot, E.3
  • 13
  • 14
    • 84890722534 scopus 로고    scopus 로고
    • Clinical and polysomnographic course of childhood narcolepsy with cataplexy
    • PID: 24142146
    • Pizza F, Franceschini C, Peltola H, Vandi S, Finotti E, Ingravallo F, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain. 2013;136(Pt 12):3787–95.
    • (2013) Brain , vol.136 , pp. 3787-3795
    • Pizza, F.1    Franceschini, C.2    Peltola, H.3    Vandi, S.4    Finotti, E.5    Ingravallo, F.6
  • 15
    • 84873387056 scopus 로고    scopus 로고
    • High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy
    • PID: 23372264
    • Poli F, Pizza F, Mignot E, Ferri R, Pagotto U, Taheri S, et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep. 2013;36(2):175–81.
    • (2013) Sleep , vol.36 , Issue.2 , pp. 175-181
    • Poli, F.1    Pizza, F.2    Mignot, E.3    Ferri, R.4    Pagotto, U.5    Taheri, S.6
  • 16
    • 33745360679 scopus 로고    scopus 로고
    • Narcolepsy–cataplexy associated with precocious puberty
    • PID: 16717224, COI: 1:STN:280:DC%2BD283ovVKgsQ%3D%3D
    • Plazzi G, Parmeggiani A, Mignot E, Lin L, Scano MC, Posar A, et al. Narcolepsy–cataplexy associated with precocious puberty. Neurology. 2006;66(10):1577–9.
    • (2006) Neurology , vol.66 , Issue.10 , pp. 1577-1579
    • Plazzi, G.1    Parmeggiani, A.2    Mignot, E.3    Lin, L.4    Scano, M.C.5    Posar, A.6
  • 18
    • 1542471912 scopus 로고    scopus 로고
    • A putative link between childhood narcolepsy and obesity
    • PID: 15033134
    • Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med. 2004;5(2):147–50.
    • (2004) Sleep Med , vol.5 , Issue.2 , pp. 147-150
    • Kotagal, S.1    Krahn, L.E.2    Slocumb, N.3
  • 19
    • 77952122423 scopus 로고    scopus 로고
    • Childhood-onset narcolepsy, obesity and puberty in four consecutive children: a close temporal link
    • PID: 20480724
    • Perriol MP, Cartigny M, Lamblin MD, Poirot I, Weill J, Derambure P, et al. Childhood-onset narcolepsy, obesity and puberty in four consecutive children: a close temporal link. J Pediatr Endocrinol Metab. 2010;23(3):257–65.
    • (2010) J Pediatr Endocrinol Metab , vol.23 , Issue.3 , pp. 257-265
    • Perriol, M.P.1    Cartigny, M.2    Lamblin, M.D.3    Poirot, I.4    Weill, J.5    Derambure, P.6
  • 20
    • 78649896476 scopus 로고    scopus 로고
    • Clinical and therapeutic aspects of childhood narcolepsy–cataplexy: a retrospective study of 51 children
    • PID: 21102987
    • Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy–cataplexy: a retrospective study of 51 children. Sleep. 2010;33(11):1457–64.
    • (2010) Sleep , vol.33 , Issue.11 , pp. 1457-1464
    • Aran, A.1    Einen, M.2    Lin, L.3    Plazzi, G.4    Nishino, S.5    Mignot, E.6
  • 22
  • 24
    • 33750130178 scopus 로고    scopus 로고
    • The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin
    • PID: 17015503
    • Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics. 2006;118(4):e1116–23.
    • (2006) Pediatrics , vol.118 , Issue.4 , pp. e1116-e1123
    • Stores, G.1    Montgomery, P.2    Wiggs, L.3
  • 25
    • 58149286309 scopus 로고    scopus 로고
    • Psychosocial and intellectual functioning in childhood narcolepsy
    • PID: 18608355
    • Dorris L, Zuberi SM, Scott N, Moffat C, McArthur I. Psychosocial and intellectual functioning in childhood narcolepsy. Dev Neurorehabil. 2008;11(3):187–94.
    • (2008) Dev Neurorehabil , vol.11 , Issue.3 , pp. 187-194
    • Dorris, L.1    Zuberi, S.M.2    Scott, N.3    Moffat, C.4    McArthur, I.5
  • 26
    • 78650290253 scopus 로고    scopus 로고
    • Clinical, polysomnographic and laboratory characteristics of narcolepsy–cataplexy in a sample of children and adolescents
    • PID: 21050810
    • Peraita-Adrados R, Garcia-Penas JJ, Ruiz-Falco L, Gutierrez-Solana L, Lopez-Esteban P, Vicario JL, et al. Clinical, polysomnographic and laboratory characteristics of narcolepsy–cataplexy in a sample of children and adolescents. Sleep Med. 2011;12(1):24–7.
    • (2011) Sleep Med , vol.12 , Issue.1 , pp. 24-27
    • Peraita-Adrados, R.1    Garcia-Penas, J.J.2    Ruiz-Falco, L.3    Gutierrez-Solana, L.4    Lopez-Esteban, P.5    Vicario, J.L.6
  • 28
    • 84893371346 scopus 로고    scopus 로고
    • Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population
    • PID: 23643648
    • Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14(6):488–92.
    • (2013) Sleep Med , vol.14 , Issue.6 , pp. 488-492
    • Ohayon, M.M.1
  • 29
    • 84900002785 scopus 로고    scopus 로고
    • Delayed diagnosis of narcolepsy: characterization and impact
    • PID: 24780133
    • Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15:502–7.
    • (2014) Sleep Med , vol.15 , pp. 502-507
    • Thorpy, M.J.1    Krieger, A.C.2
  • 30
    • 67650447016 scopus 로고    scopus 로고
    • The economic consequences of narcolepsy
    • PID: 19960645
    • Jennum P, Knudsen S, Kjellberg J. The economic consequences of narcolepsy. J Clin Sleep Med. 2009;5(3):240–5.
    • (2009) J Clin Sleep Med , vol.5 , Issue.3 , pp. 240-245
    • Jennum, P.1    Knudsen, S.2    Kjellberg, J.3
  • 31
    • 84904687579 scopus 로고    scopus 로고
    • Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther. 2014. [Epub ahead of print]
    • Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther. 2014. [Epub ahead of print].
  • 32
    • 84901785541 scopus 로고    scopus 로고
    • Quality of life in children with narcolepsy and cataplexy
    • Lecendreux M. Quality of life in children with narcolepsy and cataplexy. Sleep Med Clin. 2014;9:211–7
    • (2014) Sleep Med Clin. , vol.9 , pp. 211-217
    • Lecendreux, M.1
  • 33
    • 9644288106 scopus 로고    scopus 로고
    • Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset
    • PID: 15562415, COI: 1:CAS:528:DC%2BD2MXit1CgtQ%3D%3D
    • Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol. 2004;56(6):905–8.
    • (2004) Ann Neurol , vol.56 , Issue.6 , pp. 905-908
    • Dauvilliers, Y.1    Carlander, B.2    Rivier, F.3    Touchon, J.4    Tafti, M.5
  • 34
    • 56349137577 scopus 로고    scopus 로고
    • Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy
    • PID: 18769859
    • Plazzi G, Poli F, Franceschini C, Parmeggiani A, Pirazzoli P, Bernardi F, et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol. 2008;255(10):1549–54.
    • (2008) J Neurol , vol.255 , Issue.10 , pp. 1549-1554
    • Plazzi, G.1    Poli, F.2    Franceschini, C.3    Parmeggiani, A.4    Pirazzoli, P.5    Bernardi, F.6
  • 35
    • 39149117391 scopus 로고    scopus 로고
    • Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function
    • PID: 18295156
    • Vitiello B. Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. Child Adolesc Psychiatr Clin N Am. 2008;17(2):459–74.
    • (2008) Child Adolesc Psychiatr Clin N Am , vol.17 , Issue.2 , pp. 459-474
    • Vitiello, B.1
  • 36
    • 34547680517 scopus 로고    scopus 로고
    • A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents
    • PID: 19300563, COI: 1:CAS:528:DC%2BD2sXps1Wns7Y%3D
    • Rugino T. A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat. 2007;3(3):293–301.
    • (2007) Neuropsychiatr Dis Treat , vol.3 , Issue.3 , pp. 293-301
    • Rugino, T.1
  • 37
    • 85099638235 scopus 로고    scopus 로고
    • Cephalon: Inc.
    • ® [modafinil] tablets US prescribing information. Frazer: Cephalon, Inc.; 2010.
    • (2010) Frazer
  • 38
    • 85099639095 scopus 로고    scopus 로고
    • Cephalon: Inc.
    • ® [armodafinil] tablets US prescribing information. Frazer: Cephalon, Inc.; 2010.
    • (2010) Frazer
  • 39
    • 0032931432 scopus 로고    scopus 로고
    • Critical review of tricyclic antidepressant use in children and adolescents
    • PID: 10230182, COI: 1:STN:280:DyaK1M3ks1OqtQ%3D%3D
    • Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(5):513–6.
    • (1999) J Am Acad Child Adolesc Psychiatry , vol.38 , Issue.5 , pp. 513-516
    • Geller, B.1    Reising, D.2    Leonard, H.L.3    Riddle, M.A.4    Walsh, B.T.5
  • 41
    • 36849065939 scopus 로고    scopus 로고
    • Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin
    • PID: 18246980
    • Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705–11.
    • (2007) Sleep , vol.30 , Issue.12 , pp. 1705-1711
    • Morgenthaler, T.I.1    Kapur, V.K.2    Brown, T.3    Swick, T.J.4    Alessi, C.5    Aurora, R.N.6
  • 42
    • 84883346377 scopus 로고    scopus 로고
    • Narcolepsy: diagnosis and management
    • Kryger MH, Roth T, Dement WC, (eds), Elsevier, St. Louis:
    • Guilleminault C, Fromherz S. Narcolepsy: diagnosis and management. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 5th ed. St. Louis: Elsevier; 2011.
    • (2011) Principles and practice of sleep medicine
    • Guilleminault, C.1    Fromherz, S.2
  • 43
    • 84868013057 scopus 로고    scopus 로고
    • A practical guide to the therapy of narcolepsy and hypersomnia syndromes
    • PID: 23065655
    • Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9(4):739–52.
    • (2012) Neurotherapeutics , vol.9 , Issue.4 , pp. 739-752
    • Mignot, E.J.1
  • 44
    • 84876815800 scopus 로고    scopus 로고
    • Pediatric narcolepsy: clinical and therapeutical approaches
    • Lecendreux M. Pediatric narcolepsy: clinical and therapeutical approaches. Handb Clin Neurol. 2013;112:839–45.
    • (2013) Handb Clin Neurol , vol.112 , pp. 839-845
    • Lecendreux, M.1
  • 45
    • 0342545934 scopus 로고    scopus 로고
    • US Modafinil in Narcolepsy Multicenter Study Group
    • Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology. 2000;54(5):1166–75.
    • (2000) Neurology , vol.54 , Issue.5 , pp. 1166-1175
  • 46
    • 33646267923 scopus 로고    scopus 로고
    • The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy
    • PID: 16684437, COI: 1:CAS:528:DC%2BD28XlsFWksLY%3D
    • Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, et al. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin. 2006;22(4):761–74.
    • (2006) Curr Med Res Opin , vol.22 , Issue.4 , pp. 761-774
    • Harsh, J.R.1    Hayduk, R.2    Rosenberg, R.3    Wesnes, K.A.4    Walsh, J.K.5    Arora, S.6
  • 47
    • 33745728203 scopus 로고    scopus 로고
    • Sodium oxybate improves excessive daytime sleepiness in narcolepsy
    • PID: 16895262
    • Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep. 2006;29(7):939–46.
    • (2006) Sleep , vol.29 , Issue.7 , pp. 939-946
    • Black, J.1    Houghton, W.C.2
  • 48
    • 0742271698 scopus 로고    scopus 로고
    • Modafinil in the treatment of excessive daytime sleepiness in children
    • PID: 14607353
    • Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med. 2003;4(6):579–82.
    • (2003) Sleep Med , vol.4 , Issue.6 , pp. 579-582
    • Ivanenko, A.1    Tauman, R.2    Gozal, D.3
  • 49
    • 84892868808 scopus 로고    scopus 로고
    • Modafinil is well tolerated in children and adolescents with excessive sleepiness and obstructive sleep apnea: a 6- week double blind study [abstract]
    • Owens J, Bogan R, Lankford A, Sheldon S. Modafinil is well tolerated in children and adolescents with excessive sleepiness and obstructive sleep apnea: a 6- week double blind study [abstract]. Sleep. 2007;30(Suppl):A88–9.
    • (2007) Sleep , vol.30 , pp. A88-A89
    • Owens, J.1    Bogan, R.2    Lankford, A.3    Sheldon, S.4
  • 50
    • 84863774625 scopus 로고    scopus 로고
    • Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy
    • PID: 22283810
    • Lecendreux M, Bruni O, Franco P, Gringras P, Konofal E, Nevsimalova S, et al. Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy. J Sleep Res. 2012;21(4):481–3.
    • (2012) J Sleep Res , vol.21 , Issue.4 , pp. 481-483
    • Lecendreux, M.1    Bruni, O.2    Franco, P.3    Gringras, P.4    Konofal, E.5    Nevsimalova, S.6
  • 51
    • 12144291325 scopus 로고    scopus 로고
    • Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy
    • Xyrem US, Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004;5(2):119–23.
    • (2004) Sleep Med , vol.5 , Issue.2 , pp. 119-123
    • Xyrem, U.S.1    Multicenter Study Group2
  • 52
    • 24344500187 scopus 로고    scopus 로고
    • Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients
    • Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med. 2005;6(5):415–21.
    • (2005) Sleep Med. , vol.6 , Issue.5 , pp. 415-421
    • Xyrem International Study Group1
  • 53
    • 33747517239 scopus 로고    scopus 로고
    • Off-label treatment of severe childhood narcolepsy–cataplexy with sodium oxybate
    • PID: 16944670
    • Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsy–cataplexy with sodium oxybate. Sleep. 2006;29(8):1025–9.
    • (2006) Sleep , vol.29 , Issue.8 , pp. 1025-1029
    • Murali, H.1    Kotagal, S.2
  • 54
    • 84860609389 scopus 로고    scopus 로고
    • Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study
    • PID: 22547897
    • Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep. 2012;35(5):709–11.
    • (2012) Sleep , vol.35 , Issue.5 , pp. 709-711
    • Lecendreux, M.1    Poli, F.2    Oudiette, D.3    Benazzouz, F.4    Donjacour, C.E.5    Franceschini, C.6
  • 55
    • 84906766206 scopus 로고    scopus 로고
    • Time to response with sodium oxybate for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients with narcolepsy [APSS 2014 Abstract 0667]
    • Bogan RK, Roth T, Schwartz J, Miloslavsky M, Scharf M. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients with narcolepsy [APSS 2014 Abstract 0667]. Sleep. 2014;37(suppl):A233.
    • (2014) Sleep , vol.37 , pp. A233
    • Bogan, R.K.1    Roth, T.2    Schwartz, J.3    Miloslavsky, M.4    Scharf, M.5
  • 56
    • 84883786938 scopus 로고    scopus 로고
    • A retrospective survey of childhood ADHD symptomatology among adult narcoleptics
    • PID: 23548870
    • Modestino EJ, Winchester J. A retrospective survey of childhood ADHD symptomatology among adult narcoleptics. J Atten Disord. 2013;17(7):574–82.
    • (2013) J Atten Disord , vol.17 , Issue.7 , pp. 574-582
    • Modestino, E.J.1    Winchester, J.2
  • 57
    • 0030775911 scopus 로고    scopus 로고
    • Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat
    • PID: 9353396, COI: 1:CAS:528:DyaK2sXnsV2msLY%3D
    • Edgar DM, Seidel WF. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther. 1997;283(2):757–69.
    • (1997) J Pharmacol Exp Ther , vol.283 , Issue.2 , pp. 757-769
    • Edgar, D.M.1    Seidel, W.F.2
  • 58
    • 70649099211 scopus 로고    scopus 로고
    • The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents
    • PID: 19928382
    • Gruner JA, Marcy VR, Lin YG, Bozyczko-Coyne D, Marino MJ, Gasior M. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep. 2009;32(11):1425–38.
    • (2009) Sleep , vol.32 , Issue.11 , pp. 1425-1438
    • Gruner, J.A.1    Marcy, V.R.2    Lin, Y.G.3    Bozyczko-Coyne, D.4    Marino, M.J.5    Gasior, M.6
  • 59
    • 77955139288 scopus 로고    scopus 로고
    • Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
    • PID: 20628632, COI: 1:CAS:528:DC%2BC3cXntlaqsrw%3D
    • Pennick M. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat. 2010;6:317–27.
    • (2010) Neuropsychiatr Dis Treat , vol.6 , pp. 317-327
    • Pennick, M.1
  • 60
    • 67650225546 scopus 로고    scopus 로고
    • A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
    • PID: 19508731
    • Wigal SB, Kollins SH, Childress AC, Squires L. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health. 2009;3(1):17.
    • (2009) Child Adolesc Psychiatry Ment Health , vol.3 , Issue.1 , pp. 17
    • Wigal, S.B.1    Kollins, S.H.2    Childress, A.C.3    Squires, L.4
  • 61
    • 77955140309 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
    • PID: 20576091
    • Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct. 2010;6:34.
    • (2010) Behav Brain Funct , vol.6 , pp. 34
    • Wigal, T.1    Brams, M.2    Gasior, M.3    Gao, J.4    Squires, L.5    Giblin, J.6
  • 62
    • 34247257281 scopus 로고    scopus 로고
    • Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
    • PID: 17577466, COI: 1:CAS:528:DC%2BD2sXlt1Gkurw%3D
    • Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–63.
    • (2007) Clin Ther , vol.29 , Issue.3 , pp. 450-463
    • Biederman, J.1    Krishnan, S.2    Zhang, Y.3    McGough, J.J.4    Findling, R.L.5
  • 64
    • 52649161328 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    • PID: 19012818, COI: 1:CAS:528:DC%2BD1cXht1Cmt7nO
    • Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–73.
    • (2008) J Clin Psychiatry , vol.69 , Issue.9 , pp. 1364-1373
    • Adler, L.A.1    Goodman, D.W.2    Kollins, S.H.3    Weisler, R.H.4    Krishnan, S.5    Zhang, Y.6
  • 65
    • 84884288612 scopus 로고    scopus 로고
    • European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    • PID: 23332456, COI: 1:CAS:528:DC%2BC3sXosFOksQ%3D%3D
    • Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, et al. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol. 2013;23(10):1208–18.
    • (2013) Eur Neuropsychopharmacol , vol.23 , Issue.10 , pp. 1208-1218
    • Coghill, D.1    Banaschewski, T.2    Lecendreux, M.3    Soutullo, C.4    Johnson, M.5    Zuddas, A.6
  • 66
    • 79951965205 scopus 로고    scopus 로고
    • Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls
    • PID: 21148631, COI: 1:CAS:528:DC%2BC3MXjslKjtLk%3D
    • Donjacour CE, Aziz NA, Frolich M, Roelfsema F, Overeem S, Lammers GJ, et al. Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls. Eur J Endocrinol. 2011;164(3):363–70.
    • (2011) Eur J Endocrinol , vol.164 , Issue.3 , pp. 363-370
    • Donjacour, C.E.1    Aziz, N.A.2    Frolich, M.3    Roelfsema, F.4    Overeem, S.5    Lammers, G.J.6
  • 67
    • 79957662618 scopus 로고    scopus 로고
    • Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls
    • PID: 21447786, COI: 1:CAS:528:DC%2BC3MXot1CnsrY%3D
    • Donjacour CE, Aziz NA, Roelfsema F, Frolich M, Overeem S, Lammers GJ, et al. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab. 2011;300(6):E1069–75.
    • (2011) Am J Physiol Endocrinol Metab , vol.300 , Issue.6 , pp. E1069-E1075
    • Donjacour, C.E.1    Aziz, N.A.2    Roelfsema, F.3    Frolich, M.4    Overeem, S.5    Lammers, G.J.6
  • 69
    • 0025775406 scopus 로고
    • Mazindol in long-term treatment of narcolepsy
    • PID: 1674093, COI: 1:STN:280:DyaK3M3is1eiuw%3D%3D
    • Alvarez B, Dahlitz M, Grimshaw J, Parkes JD. Mazindol in long-term treatment of narcolepsy. Lancet. 1991;337(8752):1293–4.
    • (1991) Lancet , vol.337 , Issue.8752 , pp. 1293-1294
    • Alvarez, B.1    Dahlitz, M.2    Grimshaw, J.3    Parkes, J.D.4
  • 70
    • 84872339899 scopus 로고    scopus 로고
    • Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review
    • PID: 23036267
    • Nittur N, Konofal E, Dauvilliers Y, Franco P, Leu-Semenescu S, Cock VC, et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med. 2013;14(1):30–6.
    • (2013) Sleep Med , vol.14 , Issue.1 , pp. 30-36
    • Nittur, N.1    Konofal, E.2    Dauvilliers, Y.3    Franco, P.4    Leu-Semenescu, S.5    Cock, V.C.6
  • 71
    • 65249166541 scopus 로고    scopus 로고
    • Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations
    • PID: 19364297
    • Moller LR, Ostergaard JR. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol. 2009;19(2):197–201.
    • (2009) J Child Adolesc Psychopharmacol , vol.19 , Issue.2 , pp. 197-201
    • Moller, L.R.1    Ostergaard, J.R.2
  • 72
    • 84890395142 scopus 로고    scopus 로고
    • Treatment of cataplexy in a three-year-old using venlafaxine
    • PID: 24340297
    • Ratkiewicz M, Splaingard M. Treatment of cataplexy in a three-year-old using venlafaxine. J Clin Sleep Med. 2013;9(12):1341–2.
    • (2013) J Clin Sleep Med , vol.9 , Issue.12 , pp. 1341-1342
    • Ratkiewicz, M.1    Splaingard, M.2
  • 73
    • 0346887119 scopus 로고    scopus 로고
    • Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy
    • PID: 14633248
    • Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res. 2003;12(4):347–8.
    • (2003) J Sleep Res , vol.12 , Issue.4 , pp. 347-348
    • Lecendreux, M.1    Maret, S.2    Bassetti, C.3    Mouren, M.C.4    Tafti, M.5
  • 74
    • 78650969835 scopus 로고    scopus 로고
    • Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy
    • PID: 21210337, COI: 1:CAS:528:DC%2BC3MXjsFOhs7k%3D
    • Knudsen S, Mikkelsen JD, Bang B, Gammeltoft S, Jennum PJ. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy. Neuropediatrics. 2010;41(5):217–22.
    • (2010) Neuropediatrics , vol.41 , Issue.5 , pp. 217-222
    • Knudsen, S.1    Mikkelsen, J.D.2    Bang, B.3    Gammeltoft, S.4    Jennum, P.J.5
  • 75
    • 36348966603 scopus 로고    scopus 로고
    • Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy
    • PID: 17762946
    • Fronczek R, Verschuuren J, Lammers GJ. Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol. 2007;254(11):1607–8.
    • (2007) J Neurol , vol.254 , Issue.11 , pp. 1607-1608
    • Fronczek, R.1    Verschuuren, J.2    Lammers, G.J.3
  • 76
    • 67349139579 scopus 로고    scopus 로고
    • No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy
    • PID: 18825431
    • Valko PO, Khatami R, Baumann CR, Bassetti CL. No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy. J Neurol. 2008;255(12):1900–3.
    • (2008) J Neurol , vol.255 , Issue.12 , pp. 1900-1903
    • Valko, P.O.1    Khatami, R.2    Baumann, C.R.3    Bassetti, C.L.4
  • 77
    • 72249099225 scopus 로고    scopus 로고
    • Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment
    • PID: 19841387, COI: 1:STN:280:DC%2BD1Mjgt1ymsw%3D%3D
    • Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology. 2009;73(16):1333–4.
    • (2009) Neurology , vol.73 , Issue.16 , pp. 1333-1334
    • Dauvilliers, Y.1    Abril, B.2    Mas, E.3    Michel, F.4    Tafti, M.5
  • 78
    • 84863591736 scopus 로고    scopus 로고
    • Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency
    • PID: 22722630
    • Knudsen S, Biering-Sorensen B, Kornum BR, Petersen ER, Ibsen JD, Gammeltoft S, et al. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency. Neurology. 2012;79(1):102–3.
    • (2012) Neurology , vol.79 , Issue.1 , pp. 102-103
    • Knudsen, S.1    Biering-Sorensen, B.2    Kornum, B.R.3    Petersen, E.R.4    Ibsen, J.D.5    Gammeltoft, S.6
  • 79
    • 33845904178 scopus 로고    scopus 로고
    • BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology
    • PID: 17005916, COI: 1:CAS:528:DC%2BD2sXjsFChsA%3D%3D
    • Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther. 2007;320(1):365–75.
    • (2007) J Pharmacol Exp Ther , vol.320 , Issue.1 , pp. 365-375
    • Ligneau, X.1    Perrin, D.2    Landais, L.3    Camelin, J.C.4    Calmels, T.P.5    Berrebi-Bertrand, I.6
  • 80
    • 33947161911 scopus 로고    scopus 로고
    • The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders
    • PID: 17288995, COI: 1:CAS:528:DC%2BD2sXjt1Smtrw%3D
    • Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, et al. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol. 2007;73(8):1157–71.
    • (2007) Biochem Pharmacol , vol.73 , Issue.8 , pp. 1157-1171
    • Parmentier, R.1    Anaclet, C.2    Guhennec, C.3    Brousseau, E.4    Bricout, D.5    Giboulot, T.6
  • 81
    • 79958026433 scopus 로고    scopus 로고
    • The histamine H3 receptor: from discovery to clinical trials with pitolisant
    • PID: 21615387, COI: 1:CAS:528:DC%2BC3MXnsFOitr0%3D
    • Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol. 2011;163(4):713–21.
    • (2011) Br J Pharmacol , vol.163 , Issue.4 , pp. 713-721
    • Schwartz, J.C.1
  • 82
    • 40849137722 scopus 로고    scopus 로고
    • An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients
    • PID: 18295497
    • Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patients. Neurobiol Dis. 2008;30(1):74–83.
    • (2008) Neurobiol Dis , vol.30 , Issue.1 , pp. 74-83
    • Lin, J.S.1    Dauvilliers, Y.2    Arnulf, I.3    Bastuji, H.4    Anaclet, C.5    Parmentier, R.6
  • 83
    • 0033588184 scopus 로고    scopus 로고
    • Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation
    • PID: 10481909, COI: 1:CAS:528:DyaK1MXlslWmsbo%3D
    • Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437–51.
    • (1999) Cell , vol.98 , Issue.4 , pp. 437-451
    • Chemelli, R.M.1    Willie, J.T.2    Sinton, C.M.3    Elmquist, J.K.4    Scammell, T.5    Lee, C.6
  • 84
    • 84885378478 scopus 로고    scopus 로고
    • Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
    • PID: 24107292, COI: 1:CAS:528:DC%2BC3sXhsFyrsbjF
    • Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 2013;12(11):1068–75.
    • (2013) Lancet Neurol , vol.12 , Issue.11 , pp. 1068-1075
    • Dauvilliers, Y.1    Bassetti, C.2    Lammers, G.J.3    Arnulf, I.4    Mayer, G.5    Rodenbeck, A.6
  • 85
    • 84862791691 scopus 로고    scopus 로고
    • Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy–cataplexy in teenagers with refractory sleepiness
    • PID: 22356925, COI: 1:CAS:528:DC%2BC38XktV2hur0%3D
    • Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimao R, et al. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy–cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol. 2012;35(2):55–60.
    • (2012) Clin Neuropharmacol , vol.35 , Issue.2 , pp. 55-60
    • Inocente, C.1    Arnulf, I.2    Bastuji, H.3    Thibault-Stoll, A.4    Raoux, A.5    Reimao, R.6
  • 86
    • 84859899795 scopus 로고    scopus 로고
    • Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy
    • PID: 22036605, COI: 1:STN:280:DC%2BC38%2Fks1Wjtg%3D%3D
    • Baier PC, Hallschmid M, Seeck-Hirschner M, Weinhold SL, Burkert S, Diessner N, et al. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med. 2011;12(10):941–6.
    • (2011) Sleep Med , vol.12 , Issue.10 , pp. 941-946
    • Baier, P.C.1    Hallschmid, M.2    Seeck-Hirschner, M.3    Weinhold, S.L.4    Burkert, S.5    Diessner, N.6
  • 87
    • 84892516058 scopus 로고    scopus 로고
    • The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy
    • PID: 24406723, COI: 1:CAS:528:DC%2BC2cXisFehsbY%3D
    • Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Goder R, Baier PC. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res. 2014;262:8–13.
    • (2014) Behav Brain Res , vol.262 , pp. 8-13
    • Weinhold, S.L.1    Seeck-Hirschner, M.2    Nowak, A.3    Hallschmid, M.4    Goder, R.5    Baier, P.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.